Just Because They're Fun Doesn't Mean They're Not Bombs

CLDN is down roughly 75% this morning, which is a good reminder of the inherent risks in the biotechnology sector, even in what has been a biotech-centric bull run over the past few years. 

To be sure, there are still actionable long setups we are stalking in the biotech space. But even mighty names like BLUE JUNO appear to be getting hit off the CLDN action. 

Just something to keep in mind regardless of what AAPL does tonight. 

Elsewhere, natural gas still cannot catch a break, or a bid, also driving home the inherent risks in buying and holding an ETF like UGAZ. 

And keep an eye on CMG this morning, to see if it can offer even a quick long scalp over $640 after last week's earnings gap down.